Position in BIIB
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$614,474
+$82,634 QoQ
Shares Held
2,844
-2.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#538
of 1,036 holders
Holding Since
Jun 2023
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Legacy Capital Group California, Inc. holds $8,650,056 across 9 Drug Manufacturers - General names. BIIB ranks #6 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
19,689 | $2,530,036 | |
| 2 | JNJ |
Johnson & Johnson
|
6,006 | $1,525,343 | |
| 3 | PFE |
Pfizer Inc
|
37,682 | $907,382 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
15,052 | $867,296 | |
| 5 | AMGN |
Amgen Inc
|
2,351 | $851,344 | |
| 6 | BIIB |
Biogen Inc.
This page
|
2,844 | $614,474 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
4,088 | $516,477 | |
| 8 | NVO |
Novo Nordisk A S
|
10,299 | $493,734 |
All Filings in BIIB
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $614,474 | 2,844 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $531,840 | 2,901 | Shares | Sole | 2026-05-04 | |
| 2024-09-30 | $348,524 | 1,798 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $379,257 | 1,636 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $224,470 | 1,041 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $252,559 | 976 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $222,570 | 866 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $214,776 | 754 | Shares | Sole | 2023-08-10 | |
| No filing history on record for this holder in this stock. | ||||||